-
All Resources
(choose a category)
-
All Resources
-
selected
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
selected
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Caring for older people
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Health service organisation and delivery
- Infectious disease
- Injuries, accidents and wounds
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Paediatrics
- Public health
- Respiratory system
- Resource Type
- Programme
- Year
- Page 1 of 1
7 results found filtered by Evidence Remove Evidence Filter Scrutiny Remove Scrutiny Filter 2007 Remove 2007 Filter 2011 Remove 2011 Filter Cancer Remove Cancer Filter Clear Search
-
Appraisal Guidance No 129: Bortezomib monotherapy for relapsed multiple myeloma
- Published
- 24 October 2007
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 124: Pemetrexed for the treatment of non-small cell lung cancer
- Published
- 22 August 2007
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 121 Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma
- Published
- 28 March 2007
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 119: Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia
- Published
- 28 March 2007
- Cycle of Improvement
- Evidence
-
Bowel Screening Programme Clinical Standards
- Published
- 09 March 2007
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 118 Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
- Published
- 24 January 2007
- Cycle of Improvement
- Evidence
-
Appraisal Guidance No 116 Gemcitabine for the treatment of metastatic breast cancer
- Published
- 24 January 2007
- Cycle of Improvement
- Evidence